Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Juno Therapeutics Inc.
DescriptionAutologous T cells expressing a chimeric antigen receptor (CAR) specific to L1 cell adhesion molecule (L1CAM; CD171)
Molecular Target L1 cell adhesion molecule (L1CAM) (CD171)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today